Valuation: C&R Research Inc.

Market Cap 22.64B 16.33M 14.02M 13.16M 12.02M 22.68M 1.56B 22.79M 156M 60.34M 786M 61.32M 59.99M 2.6B P/E 2024
17.1x
P/E 2025 19.9x
Enterprise Value 19.97B 14.4M 12.36M 11.6M 10.6M 20M 1.37B 20.1M 137M 53.21M 693M 54.08M 52.9M 2.3B EV / Sales 2024
0.98x
EV / Sales 2025 0.75x
Free-Float
36.73%
Yield 2024
0.86%
Yield 2025 -
1 day+0.93%
1 week-1.86%
Current month+10.53%
1 month-0.20%
3 months-38.68%
6 months-55.91%
Current year-56.60%
1 week 1,881
Extreme 1881
2,095
1 month 1,671
Extreme 1671
2,095
Current year 1,667
Extreme 1667
4,870
1 year 1,667
Extreme 1667
5,890
3 years 1,667
Extreme 1667
11,975
5 years 1,667
Extreme 1667
13,400
10 years 1,667
Extreme 1667
13,400
Manager TitleAgeSince
Chief Executive Officer 74 2021-12-07
Director of Finance/CFO 49 -
President 56 -
Director TitleAgeSince
Director/Board Member 74 2021-12-07
Director/Board Member 62 2021-10-27
Director/Board Member 46 -
Date Insider Type Main position Quantity % Market Cap.
12/22/24 Sell 73,163 0.1290%
9/23/24 Buy 6,675 0.0118%
9/23/24 Buy 13,325 0.0236%
Change 5-day change 1-year change 3-year change Capi.($)
+0.93%-1.86%-61.97%-70.52% 16.21M
-1.01%+1.48%+1.66%+24.19% 51.65B
+1.92%+0.36%+477.97%+550.09% 45.31B
+0.81%+4.91%+39.28%+19.41% 42.7B
-0.15%-0.28%+21.65%+89.41% 42.79B
-2.27%-3.02%+14.22%+51.50% 32.87B
+0.81%+1.77%+31.91%+138.26% 17.14B
-1.08%-3.61% - - 16.61B
-1.70%+3.06%+11.11%+30.36% 15.01B
-0.85%+1.76%+80.26%+47.26% 14.21B
Average -0.50%+1.87%+68.45%+97.77% 27.83B
Weighted average by Cap. -0.58%+1.86%+101.90%+137.62%

Financials

2024 2025
Net sales 59.69B 43.05M 36.95M 34.68M 31.67M 59.78M 4.11B 60.07M 410M 159M 2.07B 162M 158M 6.86B 64.98B 46.87M 40.23M 37.76M 34.48M 65.08M 4.47B 65.39M 447M 173M 2.26B 176M 172M 7.47B
Net income 3.84B 2.77M 2.38M 2.23M 2.04M 3.84M 264M 3.86M 26.39M 10.23M 133M 10.39M 10.17M 441M 2.59B 1.86M 1.6M 1.5M 1.37M 2.59M 178M 2.6M 17.78M 6.89M 89.73M 7M 6.85M 297M
Net Debt -7.67B -5.53M -4.75M -4.46M -4.07M -7.69M -528M -7.72M -52.76M -20.45M -266M -20.78M -20.33M -882M -2.67B -1.93M -1.66M -1.55M -1.42M -2.68M -184M -2.69M -18.39M -7.13M -92.8M -7.24M -7.08M -307M
Logo C&R Research Inc.
C&R Research Inc is a Korea-based company is mainly engaged in the clinical trial agency and drug development business. The Company is mainly engaged in the provision of comprehensive early-stage clinical services in the areas of medical writing, regulatory matters, data management, biostatistics and others. The Company is mainly engaged in the provision of consulting services including initial clinical development, clinical trial development, global clinical trial development and others. In addition, the Company is also engaged in the operation of clinical trial training center.
Employees
510
Date Price Change Volume
26-08-26 ₩1,970.00 +0.87% 9,402
26-08-25 ₩1,953.00 +0.93% 6,110
26-08-24 ₩1,935.00 -0.87% 5,694
26-08-21 ₩1,952.00 -1.46% 6,459
26-08-20 ₩1,981.00 -0.40% 4,473
  1. Stock Market
  2. Stocks
  3. A359090 Stock